Annual Book Value
$103.70 M
$101.47 M-44.72%
31 December 2023
Summary:
Poseida Therapeutics annual book value is currently $103.70 million, with the most recent change of +$101.47 million (-44.72%) on 31 December 2023. During the last 3 years, it has fallen by -$158.27 million (-60.41%). PSTX annual book value is now -60.41% below its all-time high of $261.97 million, reached on 31 December 2020.PSTX Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Book Value
$87.21 M
+$26.39 M+43.40%
30 September 2024
Summary:
Poseida Therapeutics quarterly book value is currently $87.21 million, with the most recent change of +$26.39 million (+43.40%) on 30 September 2024. Over the past year, it has dropped by -$36.45 million (-29.48%). PSTX quarterly book value is now -70.52% below its all-time high of $295.84 million, reached on 30 September 2020.PSTX Quarterly Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTX Book Value Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -44.7% | -29.5% |
| 3 y3 years | -60.4% | -41.9% |
| 5 y5 years | +235.2% | - |
PSTX Book Value High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -60.4% | at low | -59.7% | +43.4% |
| 5 y | 5 years | -60.4% | +169.4% | -70.5% | +142.5% |
| alltime | all time | -60.4% | +169.4% | -70.5% | +142.5% |
Poseida Therapeutics Book Value History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $87.21 M(+43.4%) |
| June 2024 | - | $60.82 M(-28.1%) |
| Mar 2024 | - | $84.59 M(-18.4%) |
| Dec 2023 | $103.70 M(-44.7%) | $103.70 M(-16.1%) |
| Sept 2023 | - | $123.66 M(-8.6%) |
| June 2023 | - | $135.30 M(-14.1%) |
| Mar 2023 | - | $157.56 M(-16.0%) |
| Dec 2022 | $187.59 M(+20.1%) | $187.59 M(-13.3%) |
| Sept 2022 | - | $216.31 M(+228.7%) |
| June 2022 | - | $65.80 M(-36.5%) |
| Mar 2022 | - | $103.70 M(-33.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $156.21 M(-40.4%) | $156.21 M(+4.0%) |
| Sept 2021 | - | $150.16 M(-19.5%) |
| June 2021 | - | $186.58 M(-18.0%) |
| Mar 2021 | - | $227.49 M(-13.2%) |
| Dec 2020 | $261.97 M(-275.2%) | $261.97 M(-11.4%) |
| Sept 2020 | - | $295.84 M(-244.1%) |
| June 2020 | - | -$205.30 M(-536.4%) |
| Mar 2020 | - | $47.04 M(-131.5%) |
| Dec 2019 | -$149.51 M(+94.9%) | -$149.51 M |
| Dec 2018 | -$76.72 M(+128.7%) | - |
| Dec 2017 | -$33.54 M | - |
FAQ
- What is Poseida Therapeutics annual book value?
- What is the all time high annual book value for Poseida Therapeutics?
- What is Poseida Therapeutics annual book value year-on-year change?
- What is Poseida Therapeutics quarterly book value?
- What is the all time high quarterly book value for Poseida Therapeutics?
- What is Poseida Therapeutics quarterly book value year-on-year change?
What is Poseida Therapeutics annual book value?
The current annual book value of PSTX is $103.70 M
What is the all time high annual book value for Poseida Therapeutics?
Poseida Therapeutics all-time high annual book value is $261.97 M
What is Poseida Therapeutics annual book value year-on-year change?
Over the past year, PSTX annual book value has changed by -$83.89 M (-44.72%)
What is Poseida Therapeutics quarterly book value?
The current quarterly book value of PSTX is $87.21 M
What is the all time high quarterly book value for Poseida Therapeutics?
Poseida Therapeutics all-time high quarterly book value is $295.84 M
What is Poseida Therapeutics quarterly book value year-on-year change?
Over the past year, PSTX quarterly book value has changed by -$36.45 M (-29.48%)